Moxifloxacin HCl Imedco Djaja Indications/Uses

Moxifloxacin HCl is indicated for the treatment of the following bacterial infections in adults (≥18 years old): Upper respiratory tract infections: Acute exacerbations of chronic bronchitis; Community-acquired pneumonia; Acute bacterial sinusitis.
Complicated of skin & skin tissue infections: which require parenteral initial treatment; to be followed by oral therapy, in patients who have alternative-agent intolerance (especially penicillin allergy), and when caused by known moxifloxacin-susceptible organisms.
Complicated intra-abdominal infections due to polymicrobial in patients with alternative-agents intolerance which is caused by known moxifloxacin-susceptible organisms.
Mild to moderate pelvic inflammatory disease (upper genital tract infections including salpingitis and endometritis), without tubo-ovarium or pelvic abscess.
Not recommended to be used as monotherapy in mild to moderate pelvic inflammatory disease but should be combined with other suitable antibacterial agents (e.g, cephalosporins) as it can increase Neisseria gonorrhoea resistance to moxifloxacin.
Moxifloxacin HCl is indicated for the treatment of previously mentioned infections if caused by moxifloxacin-sensitive bacteria.